TrialHeadache
Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose-ranging, double-blind, randomized controlled trial.
Koichi Ikeda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
pooled ittrialcites it